Skystar Bio - Pharmaceutical Company (SKBI)
News
| May 18 | Health Care Sector Wrap Fox Business |
| May 16 | Skystar Bio-Pharmaceutical Reports First Quarter 2012 Results Marketwire |
| May 15 | $SKBI filed latest Quarterly Report http://stks.co/3qDI by MarketBrief |
| May 15 | SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report |
| May 11 | Skystar to File First Quarter Fiscal Year 2012 on Tuesday, May 15 Marketwire |
| May 02 | Skystar Bio-Pharmaceutical Regains NASDAQ Compliance Marketwire |
| Apr 27 | SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Submission of Matters to a Vote of ... |
| Apr 18 | $SKBI forms bullish "Bottom Triangle" chart pattern. http://stks.co/3PIs by RecogniaEvents |
| Apr 10 | Form 10 K for Skystar Bio-Pharmaceutical Company |
| Apr 02 | $SKBI hod pop by tradueruski |
| Mar 13 | $SKBI look at cbis 2nd best ytd of 843 healthcare ind. good press releases judge 4 yourself source is schwab research yesterday by DrewP |
| Feb 14 | $SKBI Plenty of value. peg .53 Profit mgn 29% cash flow+$2, ROE 22% by rtk |
Profile
Exchange: NASDAQCM Sector: Healthcare Industry: Drug Manufacturers - Major
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Skystar Bio - Pharmaceutical Company is down 43.55% over the last year vs S&P 500 Total Return up 0.88%, China Shenghuo Pharmaceutical down 83.00%, and China Pharma down 86.27%.
- SKBI Total Returns
- ^SPXTR Total Returns
- KUN Total Returns
- CPHI Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these SKBI related companies
Pro Strategies Featuring SKBI
Did Skystar Bio - Pharmaceutical Company make it into our Pro Portfolio Strategies?
SKBI Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other SKBI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SKBI | 2.32 | -0.07 | -2.93% | 16.61M |
| SJW | 23.07 | +0.05 | +0.22% | 428.63M |
| SJT | 13.60 | -1.18 | -7.98% | 688.90M |
| SJR | 18.92 | -0.08 | -0.42% | 7.936B |
| SB | 6.41 | +0.02 | +0.31% | 485.00M |
| SAVE | 20.52 | -0.11 | -0.53% | 1.396B |
| SATS | 28.00 | +0.18 | +0.65% | 2.411B |
| SATC | 0.3387 | -0.01 | -3.37% | 46.24M |
| SASR | 17.70 | +0.17 | +0.97% | 422.47M |
| SAPX | 0.057 | +0.00 | +2.15% | 2.005M |
